Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2008.406 | Development of an Outcome Measure for Hong Kong chinese Women with Breast Cancer-related Lymphoedema | Ms. KO Pik-ha, Betty |
| 2021.306 | The effects of evidence-based yoga protocol on physical and psychological outcomes among community-dwelling older adults. Randomized control trial. |
Ms. KO Ka Yan 高嘉恩 |
| 2022.120 | Tropism and pathogenesis of influenza virus and coronavirus in human brain explant culture |
Dr. KO Ho 高浩 |
| 2019.155 | Surface-enhanced Raman spectroscopy of cerebrospinal fluid for diagnosis of neurodegenerative diseases: a proof-of-concept study |
Prof. KO Ho 高浩 |
| 2026.605 | Chinese University- Alzheimer's Disease with Vascular and other Co-pathology: Towards Actionable Neuro- Cognitive-Omic Evaluations | Prof. Ko Ho |
| 2015.400 | Screening for cognitive impairment of the elderly in-patients of an acute general hospital. |
Dr. KO Flora 高淑蘭 |
| 2016.552 | Efficacy of influenza vaccination on patients with chronic obstructive pulmonary disease and asthma. |
Dr. KO Fanny Wai San 古惠珊 |
| 2017.311 | A cross-sectional study to assess the proportion and clinical characteristics of Asthma and COPD overlap for patients with asthma and COPD in Hong Kong. |
Dr. KO Fanny Wai San 古惠珊 |
| 2026.528 | Clinical characteristics for airway patients in Hong Kong – A territory wide study | Dr. KO Fanny Wai San |
| 2026.503 | Burden of adult respiratory tract infections and the risk factors for adverse outcomes – A territory wide cohort study | Dr. KO Fanny Wai San |
| 2012.545 | Effect of short course out-patient pulmonary rehabilitation on the activity and frequency of exacerbations of patients with chronic obstructive pulmonary disease | Dr. KO Fanny Wai San |
| 2010.195 | Prevalence of undiagnosed COPD and their systemic inflammation among patients with pre-existing cardiovascular disease | Dr. Ko Fanny Wai San |
| 2011.146 | A prospective study of factors related to readmission and mortality of COPD patients in Hong Kong | Dr. KO Fanny Wai San |
| 2013.057 | HETEROGENEITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN ASIANS | Dr. KO Fanny Wai San |
| 2014.081 | Disease impact of COPD on bone health, physical and cognitive function | Dr. KO Fanny Wai San |
| 2018.042 | Clinical phenotype of Chronic Obstructive Pulmonary Disease (COPD): retrospective medical records review | Dr. KO Fanny Wai San |
| 2019.395 | Level of FeNO in Chinese Asthma Patients |
Dr. KO Fanny Wai San 古惠珊 |
| 2025.669 | International Severe Asthma Registry | Dr. Ko Fanny Wai San |
| 2025.584 | Local epidemiology, prevalence and clinical outcomes of subjects with preserved ratio impaired spirometry | Dr. KO Fanny Wai San |
| 2025.798 | A prospective study of cardiovascular risk of patients admitted for acute exacerbation of COPD | Dr. Ko Fanny Wai San |
| 2025.429 | Viral infections and subsequent development of acute respiratory distress syndrome and interstitial lung disease | Dr. KO Fanny Wai San |
| 2025.641 | Developing a Digital Self-Guided Breathlessness Supportive Intervention for Patients with Chronic Breathlessness due to Cancer and Chronic Respiratory Diseases | Dr. Ko Fanny Wai San |
| 2025.445 | A Prospective Study on Asthma and Chronic Obstructive Pulmonary Disease (COPD) Phenotypes, Endotypes and Treatable Traits for the Planning of Further Intervention Studies | Dr. KO Fanny Wai San |
| 2025.228 | Use of biologics for severe asthma in Hong Kong | Dr. KO Fanny Wai San |
| 2024.655 | COPD Phenotypes, Endotypes and Treatable Traits in Hong Kong | Dr. KO Fanny Wai San |
| 2020.518 | Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma |
Dr. KO Fanny Wai San 古惠珊醫生 |
| 2022.167 | Telemedicine for out-patient management of adult asthma patients, effect on quality of life and asthma control, a randomised control trial. |
Dr. KO Fanny Wai San 古惠珊 |
| 2022.679 | Predicting adverse outcomes using machine learning of COPD patients in Hong Kong | Dr. KO Fanny Wai San |
| 2020.507 | To assess the management of patients on Global Initiative of Asthma (GINA) step 4 and 5 treatment in Hong Kong |
Dr. KO Fanny Wai San 古惠珊醫生 |
| 2023.330 | Genetic association with various severities, phenotypes and endotypes of asthma | Dr. KO Fanny Wai San |
| 2009.140 | A Study on the Smoking-related Lung Function Abnormalities in Chinese Subjects | Dr. Ko Fanny |
| 2017.009 | Does Tai Chi increase cerebral and peripheral muscle oxygenation and do these changes relate to improved cognitive and physical performance in people with Chronic Obstructive Pulmonary Disease (COPD)? A randomised controlled trial | Dr. KO Fanny |
| 2010.076 | Functional Characterization of the role of Sirtuin 1 (SIRT1) in hepatocellular carcinoma | Dr. Ko Chi Bun |
| 2013.131 | Functional characterization of CCCTC-binding factor (CTCF) in the growth and metastasis of heptaocellular carcinoma | Dr Ko Chi Bun |
| 2021.108 | Magnetic Resonance Imaging Screening for Nasopharyngeal Carcinoma: Artificial Intelligence for Automatic Detection | Dr. KING Ann D. |
| 2023.015 | Artificial intelligence for automatic detection of recurrent nasopharyngeal carcinoma on magnetic resonance imaging |
Dr. KING Ann D. 金雅桃 |
| 2021.609 | Repeatability of magnetic resonance imaging (MRI) radiomics features in the Head and Neck |
Prof. KING Ann D. 金雅桃 |
| 2024.643 | Staging nasopharyngeal cancer (NPC) by magnetic resonance imaging (MRI): potential new criteria for primary tumour (T) and nodal (N) categorisation | Prof. KING Ann D. |
| 2024.296 | Patterns of cancer spread on imaging in patients with nasopharyngeal carcinoma (NPC) and patterns of extranodal extension from metastatic nodes in head and neck cancer, for educational purpose | Prof. KING Ann D. |
| 2026.099 | MRI screening for nasopharyngeal carcinoma: diffusion derived vessel density (DDVD), arterial spin labeling (ASL) and macromolecular proton fraction-spin lock (MPF-SL) for improving discrimination between cancer and benign hyperplasia. | Prof. KING Ann D. |
| 2005.335 | Proton Magnetic Resonance Spectroscopy (1H-MRS) for the Investigation of Benign and Malignant Tumours of the Head and Neck | Prof. KING Ann D. |
| 2019.026 | T1rho magnetic resonance imaging (MRI) of nasopharyngeal carcinoma | Dr. KING Ann D. |
| 2019.092 | Retrospective analysis of the MRI appearance of the normal nasopharynx | Dr. KING Ann D. |
| 2019.709 | Retrospective analysis of head and neck magnetic resonance imaging (MRI) in patients with head and neck tumours | Prof. KING Ann |
| 2011.465 | Detection of nasopharyngeal carcinoma by magnetic resonance imaging (MRI): diagnostic accuracy of MRI compared to that of endoscopy and endoscopic biopsy, based on a follow-up study to determine final diagnosis | Prof King Ann |
| 2011.581 | Diffusion-Weighted MRI for Head and Neck Cancer beyond Monoexponential Model | Dr. KING Ann |
| 2013.044 | Retrospective analysis of head and neck magnetic resonance imaging (MRI) in patients with head and neck non-Hodgkin lymphoma (NHL) | Prof. KING Ann |
| 2013.045 | Retrospective analysis of head and neck magnetic resonance imaging (MRI) in patients with nasopharyngeal carcinoma (NPC) | Prof. KING Ann |
| 2013.242 | Retrospective analysis of head and neck magnetic resonance imaging (MRI) in patients with head and neck squamous cell carcinoma (SCC) | Prof. KING Ann |
| 2011.464 | Analysis of magnetic resonance imaging of the nasopharynx in patients with suspected and biopsy proven nasopharyngeal carcinoma | Prof. KING Ann |
Page 173 of 289.

